Refreshing results…
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis
Download from doi.orgPatients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study
UploadMissing publications? Search for publications with a matching author name.